Form S-3 RenovoRx Inc For: 16 April
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
RenovoRx Inc (RNXT)
RenovoRx Inc stock price live, this page displays NASDAQ RNXT stock exchange data. View the RNXT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the RenovoRx Inc real time stock price chart below.
What Is the RenovoRx Inc Stock Price Today?
The RenovoRx Inc stock price today is 0.891.
What Is the Stock Symbol for RenovoRx Inc?
The stock symbol for RenovoRx Inc is "RNXT."
What Stock Exchange Does RenovoRx Inc Trade On?
RenovoRx Inc is listed and trades on the NASDAQ stock exchange.
Is RenovoRx Inc a Good Stock to Buy?
Determining whether RenovoRx Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RNXT quote. (ISIN: US75989R1077) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
What Is the RenovoRx Inc Stock Price Today?
The RenovoRx Inc stock price today is 0.891.
What Is the Stock Symbol for RenovoRx Inc?
The stock symbol for RenovoRx Inc is "RNXT."
What Stock Exchange Does RenovoRx Inc Trade On?
RenovoRx Inc is listed and trades on the NASDAQ stock exchange.
Is RenovoRx Inc a Good Stock to Buy?
Determining whether RenovoRx Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RNXT quote. (ISIN: US75989R1077) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
NASDAQ
Currency in USD
0.891
-0.009(-0.99%)
Real-time Data·
Fair Value
An estimate of a RenovoRx's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.890
0.930
52 wk Range
0.701
1.450
RNXT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a RenovoRx's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.8900.930
52 wk Range
0.7011.450
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RNXT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a RenovoRx's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
6.875
Upside
+671.60%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- Form 8K RenovoRx Inc For: 27 March
- Investing.com
- Form S-3 RenovoRx Inc For: 16 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Mountain View, California.
RenovoRx Inc Earnings Call Summary for Q4/2025
- RenovoRx posted $238K Q4 revenue, $1.1M full-year in first commercialization year; gross margin reached 88% despite modest sales figures.
- Company raised $10M in financing to fund commercial expansion, targeting growth from 12 to 36 active centers by end of 2026.
- TIGeR-PaC trial enrollment expected mid-2026 with final data in 2027; management projects 2026 revenue of $4.25M.
- Cash position stood at $7M as of Dec 31, 2025; R&D expenses totaled $6.3M for full year, SG&A expenses reached $7M annually.
- Stock gained 27% YTD despite profitability not expected this year; analyst price targets range from $2.75 to $13 with strong buy consensus.
Last Updated: 31/03/2026, 00:12
Read Full TranscriptCompare RNXT to Peers and Sector
Metrics to compare | RNXT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRNXTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.3x | 0.0x | −0.4x | |
PEG Ratio | −0.11 | −0.38 | 0.00 | |
Price/Book | 4.6x | 2.5x | 2.6x | |
Price / LTM Sales | 39.9x | 81.9x | 3.2x | |
Upside (Analyst Target) | - | 220.8% | 46.7% | |
Fair Value Upside | Unlock | 28.3% | 7.6% | Unlock |
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 6.875
(+671.60% Upside)
Earnings
Latest Release
Mar 30, 2026
EPS / Forecast
-0.08 / -0.08
Revenue / Forecast
238K / 435.93K
People Also Watch
FAQ
What Is the RenovoRx (RNXT) Stock Price Today?
The RenovoRx stock price today is 0.891 USD.
What Stock Exchange Does RenovoRx Trade On?
RenovoRx is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for RenovoRx?
The stock symbol for RenovoRx is "RNXT."
What Is the RenovoRx (RNXT) Afterhours Price Today? (Afterhours variable test: 0.875) Current Date: Apr 24, 2026
After hours price: 0.875. After hours price change (units): -0.025. Price change percentage: -2.780%
What Is the RenovoRx Market Cap?
As of today, RenovoRx market cap is 40.550M USD.
What Is RenovoRx's Earnings Per Share (TTM)?
The RenovoRx EPS (TTM) is -0.316.
When Is the Next RenovoRx Earnings Date?
RenovoRx will release its next earnings report on May 18, 2026.
From a Technical Analysis Perspective, Is RNXT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has RenovoRx Stock Split?
RenovoRx has split 0 times.
How Many Employees Does RenovoRx Have?
RenovoRx has 17 employees.
What is the current trading status of RenovoRx (RNXT)?
As of Apr 24, 2026, RenovoRx (RNXT) is trading at a price of 0.891 USD, with a previous close of 0.900 USD. The stock has fluctuated within a day range of 0.890 USD to 0.930 USD, while its 52-week range spans from 0.701 USD to 1.450 USD.
What Is RenovoRx (RNXT) Price Target According to Analysts?
The average 12-month price target for RenovoRx is 6.875 USD, with a high estimate of 13.5 USD and a low estimate of 3 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +671.60% Upside potential.
What Is the RNXT Premarket Price?
RNXT's last pre-market stock price is 0.957 USD. The pre-market share volume is 1,780.000, and the stock has decreased by 0.057, or 6.330%.
What Is the RNXT After Hours Price?
RNXT's last after hours stock price is 0.875 USD, the stock has decreased by -0.025, or -2.780%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.